Medtronic (MDT) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY25 EPS Guidance
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $91.75 -0.41%
EPS Growth %: -2.2%
Financial Fact:
Diluted earnings per share: 0.98
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: -2.2%
Financial Fact:
Diluted earnings per share: 0.98
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Medtronic (NYSE: MDT) reported Q2 EPS of $1.26, $0.01 better than the analyst estimate of $1.25. Revenue for the quarter came in at $8.4 billion versus the consensus estimate of $8.28 billion.
GUIDANCE:
Medtronic sees FY2025 EPS of $5.44-$5.50, versus the consensus of $5.45.
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GameStop CEO Cohen buys 1.15M shares
- Lilly breaks ground on $6.5B Houston drug manufacturing site
- Vicor raises Q3 2026 revenue guidance on new licensing deal
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
